Autism Spectrum Disorders: a Review of Measures for Clinical, Health Services and Cost-effectiveness Applications

Overview

Journal Expert Rev Pharmacoecon Outcomes Res

Date 2012 Sep 14

PMID 22971035

Citations 31

Authors

Nalin Payakachat

J Mick Tilford

Erica Kovacs

Karen Kuhlthau

Affiliations

Soon will be listed here.

Abstract

Autism spectrum disorders (ASDs) are characterized by impairments in social interaction, communication and behavioral functioning that can affect the health-related quality-of-life outcomes of the affected child and the family. ASDs have increased in prevalence, leading to a demand for improved understanding of the comparative effectiveness of different pharmacologic, behavioral, medical and alternative treatments for children as well as systems for providing services. This review describes outcome instruments that can be used for clinical, health services and cost-effectiveness applications. There is a pressing need to identify the most appropriate instruments for measuring health-related quality-of-life outcomes in this population. Studies evaluating the cost-effectiveness of interventions or treatments for children with ASDs using the cost per quality-adjusted life year metric are lacking. Researchers have the potential to contribute greatly to the field of autism by quantifying outcomes that can inform optimal treatment strategies.

Citing Articles

Evaluating the Verbal Behavior Milestones Assessment and Placement Program (VB-MAPP) Scores Using Principal Components Analysis.

Peterson T, Dodson J, Sherwin R, Strale Jr F Cureus. 2024; 16(8):e66602.

PMID: 39258036 PMC: 11385427. DOI: 10.7759/cureus.66602.

An Internal Consistency Reliability Study of the Catalyst Datafinch Applied Behavior Analysis Data Collection Application With Autistic Individuals.

Peterson T, Dodson J, Sherwin R, Strale Jr F Cureus. 2024; 16(4):e58379.

PMID: 38756301 PMC: 11097292. DOI: 10.7759/cureus.58379.

Effectiveness of IMPUTE ADT-1 mobile application in children with autism spectrum disorder: An interim analysis of an ongoing randomized controlled trial.

Panda P, Elwadhi A, Gupta D, Palayullakandi A, Tomar A, Singh M J Neurosci Rural Pract. 2024; 15(2):262-269.

PMID: 38746516 PMC: 11090578. DOI: 10.25259/JNRP_599_2023.

Emotion regulation and social responsiveness in adults with autism spectrum disorder.

Roy A, Jahan F J Neurosci Rural Pract. 2023; 14(2):276-279.

PMID: 37181185 PMC: 10174144. DOI: 10.25259/JNRP_19_2022.

Analysis of research on the effectiveness of using probiotics for children with autism spectrum disorders, in order to reduce the core and accompanying autism symptoms. Review of randomized clinical trials.

Brzoska-Konkol E, Remberk B, Papasz-Siemienuk A Postep Psychiatr Neurol. 2023; 31(1):25-34.

PMID: 37082415 PMC: 9881571. DOI: 10.5114/ppn.2022.115244.

References

Aman M, Singh N, Stewart A, Field C . The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985; 89(5):485-91. View

Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J . Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2009; 125(1):e17-23. PMC: 4951085. DOI: 10.1542/peds.2009-0958. View

Limbers C, Ripperger-Suhler J, Heffer R, Varni J . Patient-reported Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in pediatric patients with attention-deficit/hyperactivity disorder and comorbid psychiatric disorders: feasibility, reliability, and validity. Value Health. 2011; 14(4):521-30. DOI: 10.1016/j.jval.2010.10.031. View

Kamp-Becker I, Schroder J, Muehlan H, Remschmidt H, Becker K, Bachmann C . Health-related quality of life in children and adolescents with autism spectrum disorder. Z Kinder Jugendpsychiatr Psychother. 2011; 39(2):123-31. DOI: 10.1024/1422-4917/a000098. View

Oyane N, Bjorvatn B . Sleep disturbances in adolescents and young adults with autism and Asperger syndrome. Autism. 2004; 9(1):83-94. DOI: 10.1177/1362361305049031. View

Payakachat N, Tilford J, Brouwer W, van Exel N, Grosse S . Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Qual Life Res. 2011; 20(9):1487-95. DOI: 10.1007/s11136-011-9870-2. View

Howlin P, Goode S, Hutton J, Rutter M . Adult outcome for children with autism. J Child Psychol Psychiatry. 2004; 45(2):212-29. DOI: 10.1111/j.1469-7610.2004.00215.x. View

Shipman D, Sheldrick R, Perrin E . Quality of life in adolescents with autism spectrum disorders: reliability and validity of self-reports. J Dev Behav Pediatr. 2010; 32(2):85-9. DOI: 10.1097/DBP.0b013e318203e558. View

Gotham K, Risi S, Pickles A, Lord C . The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J Autism Dev Disord. 2006; 37(4):613-27. DOI: 10.1007/s10803-006-0280-1. View

10.

Mayes S, Calhoun S . Ability profiles in children with autism: influence of age and IQ. Autism. 2003; 7(1):65-80. DOI: 10.1177/1362361303007001006. View

11.

Brouwer W, van Exel N, van Gorp B, Redekop W . The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006; 15(6):1005-21. DOI: 10.1007/s11136-005-5994-6. View

12.

Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burstrom K, Cavrini G . Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010; 19(6):887-97. PMC: 2892614. DOI: 10.1007/s11136-010-9649-x. View

13.

Canitano R, Scandurra V . Psychopharmacology in autism: an update. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 35(1):18-28. DOI: 10.1016/j.pnpbp.2010.10.015. View

14.

Varni J, Seid M, Kurtin P . PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001; 39(8):800-12. DOI: 10.1097/00005650-200108000-00006. View

15.

Allik H, Larsson J, Smedje H . Health-related quality of life in parents of school-age children with Asperger Syndrome or High-Functioning Autism. Health Qual Life Outcomes. 2006; 4:1. PMC: 1360061. DOI: 10.1186/1477-7525-4-1. View

16.

Green J, Charman T, McConachie H, Aldred C, Slonims V, Howlin P . Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial. Lancet. 2010; 375(9732):2152-60. PMC: 2890859. DOI: 10.1016/S0140-6736(10)60587-9. View

17.

Lovaas O . Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol. 1987; 55(1):3-9. DOI: 10.1037//0022-006x.55.1.3. View

18.

Brouwer W, van Exel N, Koopmanschap M, Rutten F . The valuation of informal care in economic appraisal. A consideration of individual choice and societal costs of time. Int J Technol Assess Health Care. 1999; 15(1):147-60. DOI: 10.1017/s0266462399152346. View

19.

Raat H, Botterweck A, Landgraf J, Hoogeveen W, Essink-Bot M . Reliability and validity of the short form of the child health questionnaire for parents (CHQ-PF28) in large random school based and general population samples. J Epidemiol Community Health. 2004; 59(1):75-82. PMC: 1763365. DOI: 10.1136/jech.2003.012914. View

20.

West L, Waldrop J, Brunssen S . Pharmacologic treatment for the core deficits and associated symptoms of autism in children. J Pediatr Health Care. 2009; 23(2):75-89. DOI: 10.1016/j.pedhc.2008.12.001. View